Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor

Published:2018-07-19 Issue:6 Volume:84 Page:E318-E333
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:Neurosurg.

Author:

Zou Ming-Xiang,Lv Guo-Hua,Wang Xiao-Bin,Huang Wei,Li Jing,Jiang Yi,She Xiao-Ling

Funder

Natural Science Foundation of Hunan Province

China Scholarship Council

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

Reference64 articles.

1. Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO);Bompas;Ann Oncol,2015

2. Operative treatment of sacrococcygeal chordoma. A review of twenty-one cases;Samson;J Bone Joint Surg Am,1993

3. Chordoma: current concepts, management, and future directions;Walcott;Lancet Oncol,2012

4. Chordoma: the nonsarcoma primary bone tumor;Chugh;Oncologist,2007

5. Prognostic Factors in Patients With Spinal Chordoma: An Integrative Analysis of 682 Patients;Zhou;Neurosurgery,2017

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathologic and prognostic characteristics of tumor budding‐like in giant cell tumor of bone;Cancer;2024-09-06

2. Hypoxic Upregulation of IER2 Increases Paracrine GMFG Signaling of Endoplasmic Reticulum Stress‐CAF to Promote Chordoma Progression via Targeting ITGB1;Advanced Science;2024-08-29

3. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone;JCO Precision Oncology;2024-08

4. The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment;Journal of Orthopaedic Surgery and Research;2024-07-15

5. Immune microenvironment and immunotherapy for chordoma;Frontiers in Oncology;2024-06-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3